Defence, Security, Energy, Utilities, Finance, Pharmaceuticals
Home > Pharmaceuticals > UK

ADC Summit 2014

19th May to 20th May 2014, London, United Kingdom

Overview

Open/Close

Antibody Drug Conjugates (ADCs) offer the promise and potential of delivering powerful tumour-killing activity with the advantage of reduced side effects for cancer patients. While one of the biggest challenges in manufacturing these powerful ADCs is controlling all the components that go into the final conjugation step, researchers do believe that further improvements and research in ADC design can and are resulting in a new generation of agents.
 

Following on from the success of past events,SMI are proud to present 3rd annual Antibody Drug Conjugates Summit, 19th-20th May 2014, London. Focusing on innovative manufacturing techniques, preclinical and clinical data and next generation ADCs, this important and timely meeting will bring together key industry experts from academia and large and small pharma and biotech companies.
 

Join us and hear case studies, presentations and round tables demonstrating how to maximise the therapeutic index of your ADC and how this form of empowered antibody is transforming next-generation antibody therapeutics. This must attend event will be delivered by true industry experts who will inform you of latest developments.


Key Topics include:-
• Exploring nano-delivery systems
• Advancing preclinical development to accelerate ADCs into the clinic
• Refining next generation ADCs
• Learn how to overcome manufacturing challenges

 

Previous testimonials include: 

“Good insight into industry knowledge and needs” – University College London

“Some excellent speakers” - Synthon

 

Benefits of Attending

Open/Close

Featured Speakers

Open/Close

Who Should Attend

Open/Close
World Courier